UnknownNCT03847571
Acetazolamide (AZ) for Management of Alkalosis in Bartter Syndrome
Studying Bartter syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Tehran University of Medical Sciences
- Principal Investigator
- Farahnak Assadi, MDRush University Medical Center
- Intervention
- Acetazolamide(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 1-10 years · All sexes
- Timeline
- 2019 – 2019
Study locations (4)
- Fateme Ghane Sharbaf, Mashhad, Iran
- Semnan University of Medical Sciences, Semnan, Iran
- Banafshe Dormansh, Tehran, Iran
- Simin Sadeghi, Zahedan, Iran
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03847571 on ClinicalTrials.gov